Erdafitinib CAS 1346242-81-6: Properties, Specifications and Research Overview

1. Product Introduction

Erdafitinib is a small-molecule compound identified by CAS No. 1346242-81-6. It is known for its ability to inhibit certain fibroblast growth factor receptors (FGFRs), which are proteins involved in cell signaling, growth, and development.

FGFR signaling is an important subject in biomedical research. Erdafitinib has an established background in FGFR-targeted cancer treatment and is discussed in scientific literature concerning receptor inhibition and related biological pathways.

For chemical buyers, confirming the compound's identity, purity, and documentation is an important part of the sourcing process. The product described here is specified as a powder with a stated purity greater than 99%. HPLC-UV is the listed analytical method. Buyers should review batch-specific documentation to verify the actual analytical results.

2. Erdafitinib Product Specifications

3. Key Product Characteristics

Chemical Identity and Purity

The CAS number and molecular formula provide useful reference information for identifying Erdafitinib. However, these details alone cannot confirm the identity or quality of a supplied batch. Appropriate analytical documentation should also be reviewed.

The stated purity is greater than 99%. HPLC-UV, or high-performance liquid chromatography with ultraviolet detection, is a method used to separate and analyze suitable chemical compounds. The actual result and testing criteria should be checked in the applicable certificate of analysis (COA).

Powder Form and Packaging

The supplied specification describes Erdafitinib as a white powder. Appearance is useful for preliminary inspection, but it cannot independently establish purity or chemical identity.

Available package formats are listed as 10 g, 100 g, 1 kg, and 25 kg. Actual packaging options depend on stock, quantity, and handling requirements. Buyers can confirm suitable formats before ordering.

4. Research Background and Applications

Erdafitinib is associated with FGFR inhibition. These receptors help transmit signals within cells, and researchers study their pathways to better understand biological processes and disease-related mechanisms.

Because of this background, Erdafitinib is relevant to scientific literature involving FGFR signaling, receptor inhibition, and targeted research. Its suitability for a particular project depends on the material's verified specifications, grade, documentation, and intended use.

A stated purity above 99% does not automatically mean that a material meets pharmaceutical manufacturing or clinical requirements. Buyers should confirm the applicable quality standards and regulatory requirements before selecting a product for specialized applications.

This description provides general chemical and sourcing information. It does not establish suitability for human administration or any specific clinical application.

5. Storage and Handling

The original product information lists storage at 2–8°C, protected from light and kept sealed. These conditions should be confirmed against the applicable technical documentation before use.

Keep the container properly closed, use suitable protective equipment, and avoid unnecessary exposure to powder. Refer to the product-specific safety data sheet (SDS) for detailed handling, exposure-control, and emergency instructions.

The listed two-year retest period should only be used when supported by relevant stability data. Storage conditions and retest information should be verified for the actual product.

6. Ordering and Shipping

For a quotation, buyers can provide the required quantity, preferred package size, destination country, and documentation requirements. This information helps confirm availability, packaging suitability, and estimated delivery time.

The stated lead time is 5–10 days, subject to order confirmation. Air or sea shipping may be available depending on destination, carrier acceptance, and applicable transport regulations. All shipments must comply with relevant import, export, and customs requirements.

Sample requests and customized packaging can be discussed before purchase.

7. Frequently Asked Questions

What is the CAS number of Erdafitinib?

The CAS number is 1346242-81-6.

What is its molecular formula?

The molecular formula is C25H30N6O2.

What purity is specified?

The supplied specification states greater than 99% purity. Confirm the batch result through the relevant COA.

Which test method is listed?

HPLC-UV is the specified analytical method.

What package sizes are available?

Listed options include 1 g, 100 g, 1 kg, and 25 kg, subject to confirmation.

How should Erdafitinib be stored?

The supplied information lists 2–8°C storage, protection from light, and sealed packaging. Confirm these conditions against product-specific documentation.

Conclusion

Erdafitinib CAS 1346242-81-6 is a small-molecule compound associated with FGFR inhibition and related research. Its supplied specifications include the molecular formula C25H30N6O2, a stated purity above 99%, and HPLC-UV testing. Buyers should verify batch documentation, storage recommendations, packaging, and regulatory suitability before ordering.